Skip to main content
search
All Posts By

Ben Kemp

HighlightsHighlights ArchiveSustainability Programme Archive

Kaye attends Responsible AI: Women & Healthcare Conference 2025

Kaye attended the Responsible AI: Women in Healthcare Conference which was held at the Royal College of Obstetrics & Gynaecology in London last week.  The meeting was chaired by Prof. Erika Denton, National Medical Director of Transformation at NHSE, and Dame Lesley Regan, Women’s Health Ambassador, and the agenda focussed on how AI could potentially help with some of the…
Ben Kemp
February 4, 2025
Membership NewsMembership News Archive

Reporting a Medical Supply Disruption

DHSC have issued a reminder to companies on how to report a medical supply disruption. Please see the guidance below: As many of you will be aware, the National Supply Disruption Response (NSDR) is the single point of contact for the UK's health and care system, and medical supply industry, in the event of medical supply disruption that may require…
Ben Kemp
February 4, 2025
Membership NewsMembership News Archive

BIVDA and NHSE Diag Task and Finish Group – Innovation in Pathology Managed Services

BIVDA is leading a Task and Finish Group under the NHS England Diagnostics Advisory Group programme which aims to test the hypothesis that the current NHS pathology Managed Equipment Service contracts restrict the procurement and adoption of new and innovative technologies in IVD markets. Currently, smaller companies and less established products struggle to gain market access through these contracts. The…
Ben Kemp
February 4, 2025
Membership NewsMembership News Archive

UKHSA Diagnostics and Research Open Framework – Market Engagement

The UKHSA Diagnostics and Research Open Framework will be tendered later this year and ahead of that procurement UK Health and Security Agency’s (UKHSA) Scientific Procurement team wishes to conduct a market engagement exercise. This consultation is intended to enhance the procurement team’s understanding of the current market in advance of the tendering of the open framework agreement later in…
Ben Kemp
February 4, 2025
European Commission Updates Regulatory Affairs NewsletterEuropean Commission Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Biocides: Upcoming active substance renewals, expiries and approvals

Apply for active substance renewal by the deadlines to keep products on the NI market 29 April 2025 Polyhexamethylene biguanide hydrochloride with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4.7 (PHMB (1415;4.7)) (CAS 1802181-67-4 / 32289-58-0 EC n/a) in product types 2 and 4 30 July 2025 Hydrogen peroxide (CAS 7722-84-1 EC 231-765-0)…
Ben Kemp
February 3, 2025
European Commission Updates Regulatory Affairs NewsletterEuropean Commission Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

EU Health Policy Platform: The 2024 Thematic Networks cycle has come to an end – what’s next?

EU Health Policy Platform: The 2024 Thematic Networks cycle has come to an end – what’s next? The 2024 Thematic Networks are now being transformed into Stakeholder and Exchange Networks, but you can continue to share your views and provide input on the health topics they deal with. The Joint Statements on which the Thematic Networks have been working on…
Ben Kemp
February 3, 2025
Close Menu